期刊文献+

五味子乙素对M146L细胞分泌β淀粉样蛋白的影响 被引量:17

Inhibition of γ-schisandrin on the production of amyloid β-protein from M146L cells
下载PDF
导出
摘要 目的:探讨五味子乙素对M146L细胞分泌的β淀粉样蛋白(amyloid β-protein,Aβ)的影响。方法:体外培养稳定转染人类阿尔茨海默病β淀粉样前体蛋白(Amyloid beta-protein precursor,APP)基因及突变型早老素1(prsenilin-1,PS1)基因的CHO(Chinese Hamster Ovary)细胞系(M146L),使之高效产生β淀粉样蛋白42(amyloid β-protein,Aβ_(42)),建立Aβ_(42)过度表达的细胞模型。加入待筛选的药物五味子乙素,用四甲基偶氮唑蓝比色法(microculture tetrazolium assay,MTT法)检测不同浓度的五味子乙素(1.67,5,15μg·mL^(-1))对M146L细胞毒作用,应用ELISA法(enzyme-linked immunosorbent assay)观察细胞分泌的Aβ_(42)的变化。结果:不同浓度的五味子乙素对M146L存活率没有影响,不具有细胞毒作用。5和15μg·mL^(-1)的五味子乙素对细胞分泌的Aβ_(42)有抑制作用,以高剂量组最为明显。结论:一定剂量的五味子乙素对M146L细胞分泌的Aβ_(42)有明显的抑制作用。 Objective: To study the effects ofγ-schisandrin on the production of amyloid β-protein 42 (Aβ_(42)) from M146L cells.Methods:Chinese hamster ovary (CHO) cells (M146L) that stably overexpress amyloid β-protein precursor for Aβ_(42) and mutant presenilin (M146L) were firstly established in vitro, and then supplemented with γ-schisandrin. The microculture tetrazolium assay (MTT assay) and enzyme-linked immunosorbent assay (ELISA) were used to evaluate the effects of γ-schisandrin (1.67,5 and 15 μg·mL-1) on Aβ_(42) production in the cell model. Results: γ-Schisandrin showed no apoptosis effects on M146L cells in MTT assay, and inhibited the Aβ_(42) production at concentrations of 5 and 15 μg·mL^(-1) in the ELISA assay. Conclusion:γ-Schisandrin potentiates to be the inhibitor of Aβ_(42) production.
出处 《中国新药杂志》 CAS CSCD 北大核心 2005年第3期290-292,共3页 Chinese Journal of New Drugs
基金 国家自然科学基金(30271502)
关键词 五味子乙素 阿尔茨海默病 Β淀粉样蛋白 M146L细胞 γ-schisandrin Alzheimer's disease amyloid β-protein M146L cell
  • 相关文献

参考文献5

  • 1肖飞,罗焕敏.靶向β和γ分泌酶治疗阿尔茨海默病的研究进展[J].国外医学(药学分册),2002,29(5):272-278. 被引量:6
  • 2Storey E,Cappai R.The amyloid precursor protein of Alzheimer's disease and the Aβ peptide[J].Neuropathol Appl Neurobiol,1999,25(2):81-97.
  • 3Selkoe DJ.Translating cell biology into therapeutic advances in Alzheimer's disease[J].Nature,1999,399(Suppl 6738):A23-A24.
  • 4Hardy J,Allsop D.Amyloid deposition as the central event in the etiology of Alzheimer's disease[J].Trends Pharmacol Sci,1991,12(10):383-388.
  • 5Xia WM,Zhang JM,Kholodenko D,et al.Enhanced production and oligomerization of the 42-residue amyloid b-protein by chinese hamster ovary cells stably expressing mutant presenilins[J].J Biol Chem,1997,272(12):7977-7982.

二级参考文献20

  • 1Storey E, Cappai R. The amyloid precursor protein of Alzheimer′s disease and the Aβ peptide[J]. Neuropathol Appl Neurobiol, 1999, 25(2):81-97.
  • 2Esler WP, Wolfe MS. A portrait of Alzheimer secretases -new features and familiar faces [J]. Science, 2001, 293(5534): 1449-1454.
  • 3Olson RE, Copeland RA. Progress towards testing the amyloid hypothesis: inhibitors of APP processing[J]. Curr Opin Drug Discov Devel, 2001, 4(4):390-401.
  • 4Buxbaum JD, Liu KN, Luo Y. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor[J]. J Biol Chen, 1998, 273(43) :27765-27767.
  • 5Vassar R, Bennett BD, Babu-Kahn S, et al. Beta-secretase cleavage of Alzheimer′s amyloid precursor protein by the transmembrane aspartic protease BACE[J]. Science, 1999,286(5440) :735-741.
  • 6Sinha S, Anderson JP, Barbour R, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain[J]. Nature, 1999, 402(6761) :537-540.
  • 7Yan R, Bienkowski MJ, Shuck ME. Membrane-anchored aspartyl protease with Alzheimer′s disease beta-secretase activity[J]. Nature, 1999,402(6761):533-537.
  • 8Hussain I, Powell D, Howlett DR, et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase[J]. Mol Cell Neurosci, 1999, 14(6) :419-427.
  • 9Lin X, Koelsch G, Wu S, et al. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid prescursor protein[J]. Proc Natl Acad Sci USA, 2000, 97(4): 1456-1460.
  • 10Ghosh AK, Shin D, Downs D, et al. Design of potent inhibitors for human brain memapsin 2 (beta-secretase) [J].JAm Chem Soc, 2000, 122:3522-3523.

共引文献5

同被引文献211

引证文献17

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部